| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |